Farnesoid X receptor (FXR): Structures and ligands (vol 19, pg 2148, 2021)

被引：0
|
作者：
Jiang, Longying [1 ,2 ]
Zhang, Huajun [2 ]
Xiao, Desheng [1 ]
Wei, Hudie [1 ,2 ]
Chen, Yongheng [1 ,2 ]
机构：
[1] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Dept Pathol,NHC Key Lab Canc Prote,Lab Struct Biol, Changsha 410008, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Dept Oncol,NHC Key Lab Canc Prote,Lab Struct Biol, Changsha 410008, Hunan, Peoples R China
来源：
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL | 2022年 / 20卷
关键词：
D O I：
10.1016/j.csbj.2022.02.0292001-0370
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1227 / 1228
页数：2
相关论文
共 50 条
  • [41] Cross-talk between farnesoid-X-receptor (FXR)and peroxisome proliferator-activated receptor γ contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis
    Fiorucci, S
    Rizzo, G
    Antonelli, E
    Renga, B
    Mencarelli, A
    Riccardi, L
    Morelli, A
    Pruzanski, M
    Pellicciari, R
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (01): : 58 - 68
  • [42] Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets
    Unsworth, Amanda J.
    Bye, Alexander P.
    Tannetta, Dionne S.
    Desborough, Michael J. R.
    Kriek, Neline
    Sage, Tanya
    Allan, Harriet E.
    Crescente, Marilena
    Yaqoob, Parveen
    Warner, Timothy D.
    Jones, Chris I.
    Gibbins, Jonathan M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37 (08) : 1482 - +
  • [43] Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets
    Moraes, Leonardo A.
    Unsworth, Amanda J.
    Vaiyapuri, Sakthivel
    Ali, Marfoua S.
    Sasikumar, Parvathy
    Sage, Tanya
    Flora, Gagan D.
    Bye, Alex P.
    Kriek, Neline
    Dorchies, Emilie
    Molendi-Coste, Olivier
    Dombrowicz, David
    Staels, Bart
    Bishop-Bailey, David
    Gibbins, Jonathan M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (12) : 2324 - 2333
  • [44] A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia
    Evans, Mark J.
    Mahaney, Paige E.
    Borges-Marcucci, Lisa
    Lai, KehDih
    Wang, Shuguang
    Krueger, Julie A.
    Gardell, Stephen J.
    Huard, Christine
    Martinez, Robert
    Vlasuk, George P.
    Harnish, Douglas C.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 296 (03): : G543 - G552
  • [45] Farnesoid X receptor (FXR): A new marker for the prediction of bone metastases in breast cancer
    Journe, Fabrice
    Durbecq, Virginie
    Chaboteaux, Carole
    Rouas, Ghislane
    Haibe-Kains, Benjamin
    IdBoufker, Hichame
    Laurent, Guy
    Sotiriou, Christos
    Larsimont, Denis
    Body, Jean-Jacques
    CANCER TREATMENT REVIEWS, 2008, 34 : S50 - S50
  • [46] INDUCTION OF P62/SQSTM1 BY FARNESOID X RECEPTOR (FXR)
    Williams, Jessica A.
    Thomas, Ann M.
    Li, Guodong
    Kong, Bo
    Xie, Wen
    Ding, Wen-Xing
    Guo, Grace L.
    HEPATOLOGY, 2011, 54 : 718A - 719A
  • [47] Discovery and optimization of benzimidazole derivatives as a novel chemotype of farnesoid X receptor (FXR) antagonists
    Teno, Naoki
    Iguchi, Yusuke
    Yamashita, Yukiko
    Mori, Nobuhiro
    Une, Mizuho
    Nishimaki-Mogami, Tomoko
    Gohda, Keigo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (06) : 1787 - 1794
  • [48] Novel FXR (farnesoid X receptor) modulators: Potential therapies for cholesterol gallstone disease
    Yu, Donna D.
    Andrali, Sreenath S.
    Li, Hongzhi
    Lin, Min
    Huang, Wendong
    Forman, Barry M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (18) : 3986 - 3993
  • [49] Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist
    Kainuma, Masahiko
    Makishima, Makoto
    Hashimoto, Yuichi
    Miyachi, Hiroyuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (07) : 2587 - 2600
  • [50] Activation of farnesoid X receptor (FXR) protects against diet-induced dyslipidemia
    Evans, M. J.
    Mahaney, P. E.
    Hartman, H. B.
    Borges-Marcucci, L.
    Huard, C.
    Lai, K.
    Martinez, R.
    Wang, S.
    Harnish, D. C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 41 - 41
12345